Vice President, Global Head Epidemiology, RTI Health Solutions

Susana Perez-Gutthann

Expertise

Pharmacoepidemiology
Risk Management
Drug Safety
Epidemiology

Biography

Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP, is vice president and global head of epidemiology at RTI Health Solutions. Her prior positions include global and European head of epidemiology at Pfizer, Pharmacia, Novartis, and Ciba-Geigy. Dr. Perez-Gutthann has 17 years of experience in multinational pharmaceutical companies, developing and leading teams of epidemiologists and driving strategy and research programs for safety, pharmacovigilance, risk management, and development. She is an active leader and past president of the International Society of Pharmacoepidemiology (ISPE), and a Fellow of ISPE and of the Royal College of Physicians, Edinburgh. Dr. Perez-Gutthann has served as an advisor to the WHO TDR Product Development and Evaluation; the International Scientific Advisory Board to MHRA General Practice Research Database; the Avon Longitudinal Study of Parents and Children (ALSPAC) Drug Safety Advisory Committee; and ISPE working groups on risk management guidances (FDA, EMEA), good pharmacoepidemiology practice, and confidentiality of patient databases in Europe.

Education

MD, PhD, Universitat de Barcelona; MPH (Postdoctoral fellowship), Epidemiology, The Johns Hopkins University.

Selected Publications

Varas-Lorenzo, C., Rodriguez, L.A., Maguire, A., Castellsague, J., & Perez-Gutthann, S. (2007 Jun). Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis, 192 (2):376-383.

Varas-Lorenzo, C., Maguire, A., Castellsague, J., & Perez-Gutthann, S. (2007 Apr). Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level. Pharmacoepidemiology and Drug Safety, 16 (4):366-376.

Varas-Lorenzo, C., Garcia-Rodriguez, L.A., Perez-Gutthann, S., & Duque-Oliart, A. (2000 Jun 6). Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Circulation, 101 (22):2572-2578.

Garcia Rodriguez, L.A., Duque, A., Castellsague, J., Perez-Gutthann, S., & Stricker, B.H. (1999 Dec). A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. British Journal of clinical pharmacology, 48 (6):847-852.

Castellsague, J., Garcia-Rodriguez, L.A., Perez-Gutthann, S., Agostinis, L., Cattaruzi, C., & Troncon, M.G. (1999 Oct). Characteristics of users of inhaled long-acting beta 2-agonists in a southern European population. Respiratory Medicine, 93 (10):709-714.

Perez-Gutthann, S., Garcia-Rodriguez, L.A., Duque-Oliart, A., & Varas-Lorenzo, C. (1999 Jul). Low-dose diclofenac, naproxen, and ibuprofen cohort study. Pharmacotherapy, 19 (7):854-859.

Jick, H., Garcia Rodriguez, L.A., & Perez-Gutthann, S. (1998 Nov 28). Principles of epidemiological research on adverse and beneficial drug effects. Lancet, 352 (9142):1767-1770.

Garcia Rodriguez, L.A., & Perez, G.S. (1998 May). Use of the UK general practice research database for pharmacoepidemiology. British Journal of clinical pharmacology, 45 (5):419-425.

Perez, G.S., Garcia Rodriguez, L.A., Castellsague, J., & Duque, O.A. (1997 Mar 15). Hormone replacement therapy and risk of venous thromboembolism: Population based case-control study. BMJ, 314 (7083):796-800.

Perez, G.S., Garcia Rodriguez, L.A., Raiford, D.S., Duque, O.A., & Ris, R.J. (1996 Nov 25). Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Archives of Internal Medicine, 156 (21):2433-2439.

View all publications by Susana Perez-Gutthann…